Zobrazeno 1 - 10
of 20
pro vyhledávání: '"David Slosky"'
Autor:
Nerea Mora-Ayestaran, MD, Angela Dispenzieri, MD, Arnt V. Kristen, MD, Mathew S. Maurer, MD, Igor Diemberger, MD, Brian M. Drachman, MD, Martha Grogan, MD, Pritam Gupta, PhD, Oliver Glass, PhD, Leslie Amass, PhD, Pablo Garcia-Pavia, MD, PhD, Michele Emdin, Mazen Hanna, Olga Azevedo, Calogero Lino Cirami, Jose Gonzalez Costello, David Slosky, Henning Moelgaard, Jose Nativi Nicolau, Scott Hummel, Eun-Seok Jeon, Nowell Fine, Srinivas Murali, Edward Miller, Sanjiv Shah, Ronald Witteles, Marcia Waddington-Cruz, Daniel Lenihan, Yoshiki Sekijima, Johan Van Cleemput, Edileide de Barros Correia, Eve Cariou, Dianna Quan, Miriam Freimer, David Steidley, Anna Hüsing-Kabar, Violaine Plante-Bordeneuve, Hans Nienhuis, Jonas Wixner, Jeffrey Ralph, Hector Ventura, Sasa Zivkovic, Diego Delgado, Roberto Fernandéz Torrón, Stephen Gottlieb, William Cotts, Jose Tallaj, Robert Brunkhorst, Michael Polydefkis, Christopher Mueller, Carsten Tschoepe, Juan Gonzalez Moreno, Nitasha Sarswat, Jin Luo, James Tauras, Alberta Warner
Publikováno v:
JACC: Advances, Vol 3, Iss 8, Pp 101086- (2024)
Background: Wild-type transthyretin amyloidosis (ATTRwt amyloidosis) is primarily diagnosed in elderly men but diagnoses in younger patients and women have recently increased. Objectives: The purpose of this study was to examine age- and sex-related
Externí odkaz:
https://doaj.org/article/dc542adf430b4e7fb29d0bce4d17c600
Autor:
Melissa Y.Y. Moey, Cassandra Hennessy, Benjamin French, Jeremy L. Warner, Matthew D. Tucker, Daniel J. Hausrath, Dimpy P. Shah, Jeanne M. DeCara, Ziad Bakouny, Chris Labaki, Toni K. Choueiri, Susan Dent, Nausheen Akhter, Roohi Ismail-Khan, Lisa Tachiki, David Slosky, Tamar S. Polonsky, Joy A. Awosika, Audrey Crago, Trisha Wise-Draper, Nino Balanchivadze, Clara Hwang, Leslie A. Fecher, Cyndi Gonzalez Gomez, Brandon Hayes-Lattin, Michael J. Glover, Sumit A. Shah, Dharmesh Gopalakrishnan, Elizabeth A. Griffiths, Daniel H. Kwon, Vadim S. Koshkin, Sana Mahmood, Babar Bashir, Taylor Nonato, Pedram Razavi, Rana R. McKay, Gayathri Nagaraj, Eric Oligino, Matthew Puc, Polina Tregubenko, Elizabeth M. Wulff-Burchfield, Zhuoer Xie, Thorvardur R. Halfdanarson, Dimitrios Farmakiotis, Elizabeth J. Klein, Elizabeth V. Robilotti, Gregory J. Riely, Jean-Bernard Durand, Salim S. Hayek, Lavanya Kondapalli, Stephanie Berg, Timothy E. O'Connor, Mehmet A. Bilen, Cecilia Castellano, Melissa K. Accordino, Blau Sibel, Lisa B. Weissmann, Chinmay Jani, Daniel B. Flora, Lawrence Rudski, Miriam Santos Dutra, Bouganim Nathaniel, Erika Ruíz-García, Diana Vilar-Compte, Shilpa Gupta, Alicia Morgans, Anju Nohria
Publikováno v:
Translational Oncology, Vol 34, Iss , Pp 101709- (2023)
Background: Data regarding outcomes among patients with cancer and co-morbid cardiovascular disease (CVD)/cardiovascular risk factors (CVRF) after SARS-CoV-2 infection are limited. Objectives: To compare Coronavirus disease 2019 (COVID-19) related co
Externí odkaz:
https://doaj.org/article/9d648aa2b95644a1af71f1806e404101
Autor:
Jose Nativi-Nicolau, Alfonso Siu, Angela Dispenzieri, Mathew S. Maurer, Claudio Rapezzi, Arnt V. Kristen, Pablo Garcia-Pavia, Samantha LoRusso, Márcia Waddington-Cruz, Olivier Lairez, Ronald Witteles, Doug Chapman, Leslie Amass, Martha Grogan, Fabio Adrian Barroso, Johan Van Cleemput, Nowell Fine, Hartmut Schmidt, Burkhard Gess, Henning Moelgaard, Violaine Planté-Bordeneuve, David Adams, Jocelyn Inamo, Giuseppe Vita, Calogero Lino Cirami, Marco Luigetti, Michele Emdin, Yoshiki Sekijima, Taro Yamashita, Eun-Seok Jeon, Maria Alejandra Gonzalez Duarte Briseno, Hans Nienhuis, Olga Azevedo, Josep Maria Campistol Plana, Juan Gonzalez Moreno, Jose Gonzalez Costello, Jonas Wixner, Yesim Parman, Sanjiv Shah, Dianna Quan, Tessa Marburger, Michael Polydefkis, Stephen Gottlieb, Jeffrey Ralph, Nitasha Sarswat, Jin Luo, Srinivas Murali, William Cotts, Brian Drachman, David Steidley, Scott Hummel, David Slosky, Hector Ventura, Daniel Jacoby, James Hoffman, James Tauras, Sasa Zivkovic, Jose Tallaj, Daniel Lenihan, Christopher Mueller
Publikováno v:
DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria
instname
JACC: CardioOncology
instname
JACC: CardioOncology
Background Transthyretin amyloid cardiomyopathy results from the accumulation of wild-type (ATTRwt) or variant (ATTRv) transthyretin amyloid fibrils in the myocardium. THAOS (Transthyretin Amyloidosis Outcomes Survey) is a global, longitudinal, obser
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5369d2058a7bfe227022ccac8c626932
http://hdl.handle.net/10641/3093
http://hdl.handle.net/10641/3093
Autor:
Rupal O'Quinn, Liping Du, Madan Jagasia, Brendan M. Weiss, Brian G. Engelhardt, David Slosky, Stacey Goodman, Daniel J. Lenihan, Joseph R. Carver, Edward A. Stadtmauer, Adetola A. Kassim, Michael R. Savona, Robert F. Cornell, Dan T. Vogl, Shelton L. Harrell, Deepak K. Gupta, Adam Waxman, Amanda M. Smith, Alfred L. Garfall, Adam D. Cohen, Bonnie Ky, Cherie N. Dahm, Trafina Jadhav, Javid Moslehi
Publikováno v:
J Clin Oncol
PURPOSE Cardiovascular adverse events (CVAEs) can occur during proteasome inhibitor (PI) therapy. We conducted a prospective, observational, multi-institutional study to define risk factors and outcomes in patients with multiple myeloma (MM) receivin
Autor:
Tyler L. Bloomer, Gregory E. Plautz, Yaomin Xu, Laura Deeanne Craig-Owens, Andrew H. Lichtman, Joshua M. Gorham, Mark A. Pilkinton, Daniel Reshef, Margaret L. Compton, Mellissa Hicks, Dan M. Roden, Christine E. Seidman, Nina Kola, Matthew R Alexander, Raquel P. Deering, Robert A. Anders, Douglas B. Johnson, Jason R Becker, Javid Moslehi, Igor J. Koralnik, Jeffrey A. Sosman, Benjamin A. Olenchock, Igor Puzanov, Spyridon Chalkias, Robert D. Hoffman, Luis A. Diaz, Jonathan S. Deutsch, David Slosky, Elizabeth J. Phillips, Janis M. Taube, Justin M. Balko, Jonathan G. Seidman
Publikováno v:
New England Journal of Medicine. 375:1749-1755
Immune checkpoint inhibitors have improved clinical outcomes associated with numerous cancers, but high-grade, immune-related adverse events can occur, particularly with combination immunotherapy. We report the cases of two patients with melanoma in
Autor:
Daniel J. Lenihan, David Slosky, Madan Jagasia, R. Frank Cornell, Javid Moslehi, Gregory Piazza, Weijuan Li
Publikováno v:
Circulation. 133:908-912
Case presentation: A 75-year-old woman was referred to cardiology for optimization of cardiovascular risk factors before starting a new cancer treatment. She was diagnosed with IgG-κ multiple myeloma (MM) 2 years previously that progressed after her
Autor:
Kyle T Rawling, Madan Jagasia, Anthony Langone, Stacey Goodman, Adetola A. Kassim, Tarsheen K. Sethi, Sarah N. Horst, Daniel J. Lenihan, Robert F. Cornell, David Slosky, Shelton L. Harrell, Sharon Phillips, Ilka Decker, Samuel M. Rubinstein, Beatrice P. Concepcion, Oluchi Oke
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 23(9)
Light chain amyloidosis (AL) results in tissue deposition of misfolded proteins, causing organ dysfunction. In an era of modern therapies, such as bortezomib, reassessment of the benefit of autologous hematopoietic cell transplantation (AHCT) should
Autor:
Tetsuro Ohba, Takashi Ando, Justin M M Cates, Jonathan G. Schoenecker, Heather A. Cole, Herbert S. Schwartz, Hirotaka Haro, David Slosky
Publikováno v:
Journal of Bone and Mineral Research. 29:1431-1445
Osteosarcoma is the most common primary malignant tumor of bone and accounts for around 50% of all primary skeletal malignancies. In addition to novel chemotherapies, there is a need for adjuvant therapies designed to inhibit osteosarcoma proliferati
Autor:
Amanda Peltier, Sara N. Horst, Rochelle Wong, Rishi D. Naik, Anthony Langone, Stacey Goodman, Roy M. John, Robert M. Hoffman, Robert C. Miller, Robert F. Cornell, David Slosky, Beatrice P. Concepcion, Thomas Reed
Publikováno v:
Gastroenterology. 154:S-280
Publikováno v:
The Journal of Heart and Lung Transplantation. 26:1061-1064
Cardiac allograft vasculopathy is the most common cause of long-term graft failure in adult and pediatric heart transplant recipients. In the absence of a specific treatment for this condition, percutaneous revascularization has been the main palliat